University of Texas, M.D. Anderson
Welcome,         Profile    Billing    Logout  
 10 Trials 
7 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Milbourne, Andrea
ART_CIN_II, NCT04098744: Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)

Recruiting
2
78
US
Artesunate vaginal insert, Artesunic acid, DHA, artemisinin, Placebo vaginal insert
Frantz Viral Therapeutics, LLC, Amarex Clinical Research, M.D. Anderson Cancer Center, Harris Health System (L.B.J. Hospital), The Cleveland Clinic, University of Michigan, Morehouse School of Medicine
CIN 2/3, HPV Infection, Pre-Cancerous Dysplasia, Cervical Dysplasia, HPV Related Disease
07/25
12/25
Schmeler, Kathleen M
ART_CIN_II, NCT04098744: Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)

Recruiting
2
78
US
Artesunate vaginal insert, Artesunic acid, DHA, artemisinin, Placebo vaginal insert
Frantz Viral Therapeutics, LLC, Amarex Clinical Research, M.D. Anderson Cancer Center, Harris Health System (L.B.J. Hospital), The Cleveland Clinic, University of Michigan, Morehouse School of Medicine
CIN 2/3, HPV Infection, Pre-Cancerous Dysplasia, Cervical Dysplasia, HPV Related Disease
07/25
12/25
White, Donna
ART_CIN_II, NCT04098744: Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)

Recruiting
2
78
US
Artesunate vaginal insert, Artesunic acid, DHA, artemisinin, Placebo vaginal insert
Frantz Viral Therapeutics, LLC, Amarex Clinical Research, M.D. Anderson Cancer Center, Harris Health System (L.B.J. Hospital), The Cleveland Clinic, University of Michigan, Morehouse School of Medicine
CIN 2/3, HPV Infection, Pre-Cancerous Dysplasia, Cervical Dysplasia, HPV Related Disease
07/25
12/25
ART-VIN IIB, NCT06075264: Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)

Recruiting
2
27
US
Artesunate ointment, Artesunic acid, Dihydroartemisinin (DHA), Artemisinin, Placebo ointment, Placebo to artesunate ointment
Frantz Viral Therapeutics, LLC, The Cleveland Clinic
Vulvar Diseases, HPV Infection, Vulvar HSIL, Pre-Cancerous Dysplasia, HPV Disease, VIN, Usual Type, VIN 2 of Usual Type, VIN 3 of Usual Type, Vin II, Vin III, VIN Grade 2, VIN Grade 3, High Grade Intraepithelial Neoplasia
12/25
12/26
ENGOT-ov60, NCT04625270 / 2020-004264-26: A Study of Avutometinib (VS-6766) V. Avutometinib (VS-6766) + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer with and Without a KRAS Mutation

Active, not recruiting
2
225
Europe, Canada, US
avutometinib (VS-6766), avutometinib (VS-6766) and defactinib, avutometinib (VS-6766) and VS-6063
Verastem, Inc., European Network of Gynaecological Oncological Trial Groups (ENGOT), GOG Foundation
Low Grade Ovarian Serous Adenocarcinoma, Ovarian Cancer
11/24
12/26
Gallegos, Jessica
ART_CIN_II, NCT04098744: Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)

Recruiting
2
78
US
Artesunate vaginal insert, Artesunic acid, DHA, artemisinin, Placebo vaginal insert
Frantz Viral Therapeutics, LLC, Amarex Clinical Research, M.D. Anderson Cancer Center, Harris Health System (L.B.J. Hospital), The Cleveland Clinic, University of Michigan, Morehouse School of Medicine
CIN 2/3, HPV Infection, Pre-Cancerous Dysplasia, Cervical Dysplasia, HPV Related Disease
07/25
12/25
NCT05978804: Home-based tDCS in Frontotemporal Dementia or Alzheimer's Disease

Enrolling by invitation
N/A
50
US
Computerized Cognitive Training via BrainHQ, Active tDCS (tDCS) on DLPFC
Johns Hopkins University, Ybrain Inc.
Mild Cognitive Impairment, Primary Progressive Aphasia, Dementia
08/25
08/25

Download Options